Heterogeneidade Fenotípica Intratumoral dos Carcinomas do Endométrio

envie a um amigo share this

Heterogeneidade Fenotípica Intratumoral dos Carcinomas do Endométrio

Segunda, 03.07.2017

A heterogeneidade fenotípica intratumoral pode ter implicações no diagnóstico, terapêutica e prognóstico dos doentes oncológicos. A heterogeneidade intratumoral deve ser avaliada de forma objetiva para se averiguar o seu efeito na variabilidade clinico-patológica, agressividade, metastização e resposta à terapêutica dos tumores. No entanto, as metodologias e estratégias que têm sido utilizadas são muito diversificadas, incluindo métodos qualitativos e, recentemente, quantitativos. Um grupo multidisciplinar de investigadores do Centro Hospitalar São João, Instituto Português de Oncologia do Porto, Instituto de Ciências Biomédicas Abel Salazar, Faculdade de Medicina do Porto, e IPATIMUP/i3S estudou a heterogeneidade fenotípica intratumoral dos carcinomas do endométrio, que são as neoplasias ginecológicas mais frequentes nas mulheres portuguesas. Avaliaram parâmetros morfológicos arquiteturais, nucleares e de imuno-expressão de recetores de progesterona e de estrogénio, TP53, beta-catenina e vimentina. A análise resultou da utilização de medidas quantitativas de dispersão e diversidade. Neste trabalho, publicado na revista International Journal of Gynecological Pathology, concluiu-se que os carcinomas do endométrio têm heterogeneidade fenotípica intratumoral variável, predominantemente baixa.


Cátia Silva MD 1,2, Ana S. Pires-Luís MD 3,4, Eduardo Rocha PhD 5, Carla Bartosch MD 2,3,4, José M. Lopes MD PhD 1,2,6

1Department of Pathology, Centro Hospitalar São João, Porto, Portugal;

2Department of Pathology and Oncology, Medical Faculty, University of Porto, Portugal;

3Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal;

4Cancer Epigenetics & Biology Group, Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal;

5Department of Microscopy, Laboratory of Histology and Embryology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Portugal;

6IPATIMUP (Institute of Molecular Pathology and Immunology, University of Porto) & I3S - Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal.


Intratumoral heterogeneity has been shown to play an important role in diagnostic accuracy, development of treatment resistance and prognosis of cancer patients. Recent studies have proposed quantitative measurement of phenotypic intratumoral heterogeneity, but no study is yet available in endometrial carcinomas. In our study we evaluated the phenotypic intratumoral heterogeneity of a consecutive series of ten endometrial carcinomas using measures of dispersion and diversity. Morphometric architectural [%tumor cells (%TC), %solid tumor (%ST), %differentiated tumor (%DT) and %lumens (%LUM)] and nuclear [volume-weighted mean nuclear volume (v ̅_V)] parameters, as well as ER, PR, p53, vimentin and beta-catenin immunoexpression (H-score) were digitally analyzed in twenty microscopic fields per carcinoma. Quantitative measures of intratumoral heterogeneity included coefficient of variation (CV) and relative quadratic entropy (rQE). In each endometrial carcinoma there was slight variation of architecture from field to field, resulting in globally low levels of heterogeneity measures (mean CV %TC:0.10, %ST:0.73, %DT:0.19, %LUM:0.61 and mean rQE %TC:18.5, %ST:20.3, %DT:25.6, %LUM:21.8). Nuclear intratumoral heterogeneity was also globally low (mean v ̅_V CV: 0.23 and rQE: 27.3), but significantly higher than the heterogeneity of architectural parameters within most carcinomas. In general, there was low to moderate variability of immunoexpression markers within each carcinoma, but ER (mean CV: 0.56 and rQE: 46.2) and PR (mean CV: 0.60 and rQE: 39.3) displayed the highest values of heterogeneity measures. Intratumoral heterogeneity of immunoexpression was significantly higher than that observed for morphometric parameters. Also, there were frequently positive correlations between heterogeneity of different immunoexpression markers. In conclusion, our study indicates that endometrial carcinomas present a variable but predominantly low degree of phenotypic intratumoral heterogeneity.

International Journal of Gynecological Pathology

https://www.ncbi.nlm.nih.gov/pubmed/28582348